You have 9 free searches left this month | for more free features.

Treatment Interruption

Showing 1 - 25 of 2,467

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperhidrosis, Children, Adolescents, Thoracoscopic Sympathetic Chain Interruption Trial in Cairo (Thoracoscopic sympathectomy,

Completed
  • Hyperhidrosis
  • +3 more
  • Thoracoscopic sympathectomy
  • +2 more
  • Cairo, Egypt
    Pediatric Surgery Department, Al-Azhar University
Nov 1, 2023

Enteral Nutrition Interruption inOncology Intensive Care Unit.

Completed
  • Critical Illness
  • Enteral Feeding
  • Al Madīnah, Saudi Arabia
    King Faisal Specialist Hospital and Research Centre
Nov 26, 2023

HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)

Recruiting
  • HIV
  • Acute Treatment Interruption
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 11, 2023

Voluntary Interruption of Pregnancy on Women's Sexuality

Not yet recruiting
  • Abortion
  • questionnaire
  • Bordeaux, France
    CHU Bordeaux
Jan 13, 2023

Ashesive Capsulitis Trial in New York (Tenex, Local anesthetic)

Active, not recruiting
  • Adhesive Capsulitis
  • Tenex
  • Local anesthetic
  • New York, New York
    Montefiore Medical Center
Jan 24, 2023

Post Analytic Treatment Interruption Study

Recruiting
  • HIV
    • Bangkok, Thailand
      SEARCH
    Oct 19, 2022

    Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Sunnybrook Research Institute
    Jul 18, 2023

    HIV/AIDS Trial in San Francisco (Treatment Interruption Arm)

    Recruiting
    • HIV/AIDS
    • Treatment Interruption Arm
    • San Francisco, California
      University of California San Francisco
    Apr 27, 2022

    Myocardial Infarction Trial in Paris (Beta-blockers withdrawal, Continuation of the Betablockers (ßB) treatment)

    Active, not recruiting
    • Myocardial Infarction
    • Beta-blockers withdrawal
    • Continuation of the Betablockers (βB) treatment
    • Paris, France
      Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière
    Oct 28, 2022

    Sedentary Behavior, Sedentary Time Trial in Chapel Hill (One 5-Minute Walking Bout Each Hour, One 15-Minute Standing Bout Each

    Recruiting
    • Sedentary Behavior
    • Sedentary Time
    • One 5-Minute Walking Bout Each Hour
    • +3 more
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill
    Jan 6, 2023

    Venous Ulcer Trial in Roscommon (Terminal Interruption of the Reflux Source, Axial Ablation)

    Recruiting
    • Venous Ulcer
    • Terminal Interruption of the Reflux Source
    • Axial Ablation
    • Roscommon, Ireland
      Roscommon Unversity Hospiral
    May 16, 2022

    HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)

    Withdrawn
    • HIV Infection
    • Analytical Treatment Interruption + bNAbs infusion
    • Milan, Lombardy, Italy
    • +3 more
    Aug 2, 2022

    HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

    Enrolling by invitation
    • HIV
    • Antiretroviral Therapy Interruption(ATI)
    • Washington, District of Columbia
    • +1 more
    Sep 12, 2022

    Monoclonal Antibody Duration of REsponse in MIgraine After

    Recruiting
    • Migraine
    • Headache, Migraine
    • Headache calendar completion
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Jul 15, 2022

    Sleep Trial in Houston (ViSi Mobile device, Sleep enhancement intervention)

    Not yet recruiting
    • Sleep
    • ViSi Mobile device
    • Sleep enhancement intervention
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 20, 2022

    Aortic Valve Disease, Aortic Valve Stenosis, Stroke Trial in Nieuwegein (Continuation of oral anticoagulants, Interruption of

    Recruiting
    • Aortic Valve Disease
    • +6 more
    • Continuation of oral anticoagulants
    • Interruption of oral anticoagulants
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Ziekenhuis
    Feb 8, 2022

    Axitinib Dose Reduction and Interruption for Adverse Event

    Completed
    • Renal Cell Carcinoma
    • New York, New York
      Pfizer
    Sep 15, 2022

    HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Los Angeles, California
    • +11 more
    Jan 13, 2023

    Human Immunodeficiency Virus Trial in Boston, New York (3BNC117, 10-1074, Analytical treatment interruption)

    Completed
    • Human Immunodeficiency Virus
    • Boston, Massachusetts
    • +1 more
    Feb 11, 2022

    HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Gaborone, Botswana
    • +10 more
    May 16, 2022

    HIV Trial in Gent (treatment interruption after in depth sampling under CART)

    Completed
    • HIV
    • treatment interruption after in depth sampling under CART
    • Gent, Oost-Vlaanderen, Belgium
      UZ Gent
    Sep 29, 2021

    Mechanical Ventilation, Respiratory Failure Trial in Long Beach (Analgesia First Sedation Strategy for Mechanically Ventilated

    Not yet recruiting
    • Mechanical Ventilation
    • Respiratory Failure
    • Analgesia First Sedation Strategy for Mechanically Ventilated (MV) Trauma Subjects
    • Protocol Directed Sedation and Daily Sedation Interruption
    • Long Beach, California
      Long Beach Memorial Medical Center
    Feb 28, 2023

    Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)

    Completed
    • Type 1 Diabetes
    • New Haven, Connecticut
      Yale University School of Medicine
    Sep 17, 2021

    Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

    Not yet recruiting
    • Human Immuno-deficiency Virus (HIV) Disease
    • (no location specified)
    Sep 5, 2023

    HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

    Not yet recruiting
    • HIV Vaccine
    • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
    • +2 more
    • São Paulo, Brazil
      Hospital das Clínicas da Faculdade de Medicina da USP
    Mar 14, 2023